Clinical Chemistry, Malmö
1 – 10 of 1361
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Spatial imaging features derived from SUVmax location in resectable NSCLC are associated with tumor aggressiveness
- Contribution to journal › Article
-
Mark
Using 18F-FDG PET/CT-derived body composition features to predict lymphovascular invasion in non-small cell lung cancer
- Contribution to journal › Article
-
Mark
Evaluation of a Particle Enhanced Turbidimetric Immunoassay (PETIA) for detecting calprotectin in sputum samples
- Contribution to journal › Article
-
Mark
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma
- Contribution to journal › Article
-
Mark
A Proteomic Study of the Dual Oncogenic and Tumor-Suppressive Roles of SIRT3 in Lung and Breast Cancer Cell Lines
- Contribution to journal › Article
-
Mark
SPAP : Soluble Human Plasma Proteoform Analysis via Acetonitrile Precipitation and Top-Down Mass Spectrometry
- Contribution to journal › Article
-
Mark
A 25-year evaluation of direct local international normalized ratio calibration of the Owren type prothrombin time method in Sweden
- Contribution to journal › Article
-
Mark
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
- Contribution to journal › Article
-
Mark
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease : 5-year Results from the IMPACT Study
- Contribution to journal › Article
-
Mark
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Contribution to journal › Article
